European Cystic Fibrosis Society

Registry Variables and Definitions

Updated 16 April 2011 

The Registry collects demographic and clinical data on all CF patients meeting the ECFS Patient Registry criteria. For a detailed list of variables, their definition and the inclusion criteria, please click here (pdf). The summary of the information collected is given hereunder.


Demographic

Follow Up

CF centre's code Date of best FEV1 registered this year
Patient's code Value of best FEV1 registered this year
Year of follow up Value of best FVC registered this year
Date of birth Height measured at date of best FEV1
Gender Weight measured at date of best FEV1
Status of patient
Cause of death

Complications

Date of death Allergic broncho-pulmonary aspergillosis this year
Diabetes: daily insulin treated this year

Genotype

Pneumotheroax requiring chest drain this year
First mutation Liver disease this year
Second mutation Hemoptysis major over 250 ml this year
Pancreatic status: faecal elastase

Therapy

Pancreatic status: faecal fat
Inhaled continuous hypertonic NaCI this year Occurrence of malignancy this year
Inhaled continuous antibiotic this year
Inhaled continuous bronchodilators this year
In oxygen therapy this year

Microbiology

Use of rhDNase this year Chronic Burkholderia cepacia complex
Use of continuous Azithromycin (or other macrolide) this year Nontuberculous mycobacteria this year
Use of ursodeoxycholic acid this year Chronic Pseudomonas aeruginosa
Use of pancreatic enzymes this year Chronic Staphylococcus aureus
Stenotrophomonas maltophilia this year

Diagnosis

Diagnosis confirmed

Transplant

Age at diagnosis Liver transplant
Type of sweat test Year of latest liver transplant (if occurred before or during this year)
Electrolytes Lung transplant
Chloride value Year of latest lung transplant (if occurred before or during this year)
Meconium Ileus
Neonatal screening